Intellipharmaceutics International Inc. (IPCIF)
OTCMKTS: IPCIF · Delayed Price · USD
0.0700
-0.0650 (-48.15%)
Apr 18, 2024, 3:17 PM EDT - Market closed
IPCIF Balance Sheet
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.08 | 0.08 | 0.77 | 0.2 | 6.64 | 1.9 | 4.14 | 1.76 | 4.23 | 0.76 | Upgrade
|
| Cash & Cash Equivalents | 0.08 | 0.08 | 0.77 | 0.2 | 6.64 | 1.9 | 4.14 | 1.76 | 4.23 | 0.76 | Upgrade
|
| Cash Growth | 0% | -89.15% | 282.06% | -96.96% | 250.11% | -54.23% | 136.12% | -58.54% | 456.67% | 53.03% | Upgrade
|
| Receivables | 0.39 | 0.39 | 0.27 | 1.05 | 1.24 | 1.33 | 1.15 | 0.94 | 1.34 | 1.66 | Upgrade
|
| Inventory | 0 | 0 | 0.11 | 0.11 | 0.25 | 0.12 | -0.68 | -0.19 | 0.1 | 0.18 | Upgrade
|
| Other Current Assets | 0.02 | 0.02 | -0.05 | 0.12 | 0.59 | 0.23 | 1.08 | 0.41 | 0.31 | 0.14 | Upgrade
|
| Total Current Assets | 0.49 | 0.49 | 1.1 | 1.48 | 8.72 | 3.56 | 5.7 | 2.92 | 5.98 | 2.73 | Upgrade
|
| Property, Plant & Equipment | 0.94 | 0.94 | 0.99 | 1.91 | 2.76 | 3.27 | 1.89 | 1.76 | 1.62 | 1.23 | Upgrade
|
| Intangible Assets | 0 | 0 | 0 | 0.01 | 0 | 0 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | -0 | -0 | -0 | -0.01 | 0 | 0.57 | 0.38 | 0.54 | 0.27 | 0.42 | Upgrade
|
| Total Long-Term Assets | 0.94 | 0.94 | 0.99 | 1.91 | 2.76 | 3.83 | 2.28 | 2.3 | 1.89 | 1.65 | Upgrade
|
| Total Assets | 1.43 | 1.43 | 2.1 | 3.39 | 11.47 | 7.4 | 7.97 | 5.22 | 7.88 | 4.38 | Upgrade
|
| Accounts Payable | 3.76 | 3.76 | 3.78 | 4.1 | 2.64 | 2.06 | 0.81 | 3.03 | 0.67 | 0.81 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0 | 0.3 | 0.3 | 0.45 | -0.23 | -1.08 | 0.27 | Upgrade
|
| Current Debt | 2.33 | 2.33 | 1.92 | 2.11 | 1.79 | 1.29 | 1.51 | 1.54 | 1.4 | 0.04 | Upgrade
|
| Other Current Liabilities | 5.92 | 5.92 | 4.55 | 3.48 | 0.58 | 1 | 1.43 | 0.86 | 1.94 | 1.67 | Upgrade
|
| Total Current Liabilities | 12.01 | 12.01 | 10.25 | 9.7 | 5.31 | 4.65 | 4.2 | 5.2 | 2.92 | 2.79 | Upgrade
|
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.04 | 2.11 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 2.06 | 2.36 | 2.66 | 0.15 | 0 | 5.44 | Upgrade
|
| Total Long-Term Liabilities | 0 | 0 | 0 | 0 | 2.06 | 2.36 | 2.66 | 0.17 | 0.04 | 7.54 | Upgrade
|
| Total Liabilities | 12.01 | 12.01 | 10.25 | 9.7 | 7.37 | 7.01 | 6.86 | 5.36 | 2.97 | 10.33 | Upgrade
|
| Total Debt | 2.33 | 2.33 | 1.92 | 2.11 | 1.79 | 1.29 | 1.51 | 1.55 | 1.44 | 2.15 | Upgrade
|
| Debt Growth | - | 21.31% | -9.24% | 18.00% | 38.74% | -14.52% | -2.89% | 7.89% | -32.94% | 2097.77% | Upgrade
|
| Common Stock | 49.18 | 49.18 | 49.18 | 46.14 | 44.33 | 26,700 | 29.83 | 0 | 18.94 | 19.67 | Upgrade
|
| Retained Earnings | -105.13 | -105.13 | -102.24 | -97.1 | -85.62 | -71.87 | -63.02 | -52.87 | -45.44 | -41.58 | Upgrade
|
| Comprehensive Income | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade
|
| Shareholders' Equity | -10.58 | -10.58 | -8.16 | -6.31 | 4.1 | 0.39 | 1.12 | -0.14 | 4.91 | -5.96 | Upgrade
|
| Total Liabilities and Equity | 1.43 | 1.43 | 2.1 | 3.39 | 11.47 | 7.4 | 7.97 | 5.22 | 7.88 | 4.38 | Upgrade
|
| Net Cash / Debt | -2.24 | -2.24 | -1.15 | -1.91 | 4.85 | 0.61 | 2.63 | 0.2 | 2.79 | -1.39 | Upgrade
|
| Net Cash / Debt Growth | - | - | - | - | 699.79% | -76.98% | 1213.17% | -92.82% | - | - | Upgrade
|
| Net Cash Per Share | -0.07 | -0.08 | -0.05 | -0.09 | 1.02 | 0.20 | 0.99 | 0.08 | 1.21 | -0.71 | Upgrade
|
| Working Capital | -11.52 | -11.52 | -9.15 | -8.22 | 3.41 | -1.08 | 1.5 | -2.28 | 3.06 | -0.06 | Upgrade
|
| Book Value Per Share | -0.32 | -0.36 | -0.35 | -0.29 | 0.86 | 0.12 | 0.42 | -0.06 | 2.13 | -3.03 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.